Guideline | Drug Name |
---|---|
Voranigo (Vorasidenib) | Voranigo (Vorasidenib) |
Vosevi (sofosbuvir/velpatasvir/voxilaprevir) | Vosevi (sofosbuvir/velpatasvir/voxilaprevir) |
Votrient (pazopanib) | Votrient (pazopanib) |
Voxzogo (vosoritide) | Voxzogo (vosoritide) |
Voydeya (danicopan) | Voydeya (danicopan) |
Vtama (tapinarof) | Vtama (tapinarof) cream |
Vuity (pilocarpine) - PA, NF | Vuity (pilocarpine) |
Vyjuvek (beremagene geperpavec-svdt) | Vyjuvek (beremagene geperpavec-svdt) |
Vyleesi (bremelanotide) | Vyleesi (bremelanotide) |
Vyndaqel (tafamidis meglumine), Vyndamax (tafamidis) | Vyndaqel (tafamidis meglumine), Vyndamax (tafamidis) |
Vyondys 53 (golodirsen) - PA, NF | Vyondys 53 (golodirsen) |
Vyvgart (efgartigimod alfa-fcab) | Vyvgart (efgartigimod alfa), Vyvgart Hytrulo (efgartigimod alfa and hyaluronidase-qvfc) |
Vyxeos (daunorubicin and cytarabine) | Vyxeos (daunorubicin and cytarabine) |
Wainua (eplontersen) | Wainua (eplontersen) |
Wakix (pitolisant) | Wakix (pitolisant) |
Welireg (belzutifan) | Welireg (belzutifan) |
Winlevi (clascoterone) cream | Winlevi (clascoterone) cream |
Xalkori (crizotinib) - PA, NF | Xalkori (crizotinib) |
Xdemvy (lotilaner) PA, NF | Xdemvy (lotilaner ophthalmic solution) |
Xeljanz, Xeljanz XR (tofacitinib) | Xeljanz (tofacitinib) tablets and oral solution, Xeljanz (tofacitinib) tablets, Xeljanz XR (tofacitinib) extended-release tablets |